PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Arizona Poison & Drug Information Center, College of Pharmacy and University of Arizona College of Medicine, University of Arizona, Tucson, AZ, USA.\', \'Faculty of Pharmacy and Pharmaceutical Sciences, Islamic Azad University, Tehran Medical Sciences University (IAUTMU), Tehran, Iran.\', \'Venom and Biotherapeutic Molecules Lab., Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, 13169-43551, Tehran, Iran.\', \'Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran.\', \'Department of Civil Eng., Sharif University of Technology, Tehran, Iran.\', \'Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.\', \'Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran. omid.mehrpour@yahoo.com.au.\', \'Data Science Institute, Southern Methodist University, Dallas, TX, USA. omid.mehrpour@yahoo.com.au.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s40001-022-00645-8
?:hasPublicationType
?:journal
  • European journal of medical research
is ?:pmid of
?:pmid
?:pmid
  • 35123559
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.55
?:rankingScore_hIndex
  • 49
?:title
  • Repurposing the drug, ivermectin, in COVID-19: toxicological points of view.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35123559>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35123559>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all